Live from the NIH registry
Studies recruiting near Corpus Christi right now
Top 25 of 66 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular
Phase 3
Interventional 750 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Pinnacle Clinical Research — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eccogene
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
North American Comfilcon A Clinical Study
Astigmatism, Presbyopia
N/A
Observational 182 participants sought
Drs. McIntyre, Garza, Avila and Jurica, Optometrists — Corpus Christi, Texas (5.3 mi)
· Sponsor: CooperVision International Limited (CVIL)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: 89bio, Inc.
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 38 — Corpus Christi, Texas (5.3 mi)
· Sponsor: BioStem Technologies
Impact of Early Fortini Initiation on Growth and Interstage Outcomes in Infants With Single Ventricle Physiology
Single-ventricle
N/A
Interventional 100 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Driscoll Children's Hospital
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
Overweight or Obesity and Elevated Liver Fat
Phase 2
Interventional 180 participants sought
Pinnacle Clinical Research - Corpus Christi — Corpus Christi, Texas (5.3 mi)
· Sponsor: Amgen
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma
Phase 2
Interventional 160 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 190 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Growth Hormone Deficiency (GHD)
Phase 3
Interventional 150 participants sought
Lumos Pharma Investigational Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: Lumos Pharma
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
CHRISTUS Spohn Cancer Center — Corpus Christi, Texas (5.3 mi)
· Sponsor: Agendia
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Acute Myeloid Leukemia
Phase 3
Interventional 1,400 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Tophaceous Gout
Phase 3
Interventional 250 participants sought
Arthritis & Osteoporosis Center of Coastal Bend — Corpus Christi, Texas (5.3 mi)
· Sponsor: Crystalys Therapeutics
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Basal Ganglia Germinoma, Diabetes Insipidus
Phase 2
Interventional 240 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
Invasive Fungal Infection
Phase 2
Interventional 40 participants sought
Driscoll Children's Hospital ( Site 2113) — Corpus Christi, Texas (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Droperidol and QTc Interval Changes in ED Patients
Emergency Department Patient, QTc Intervals Changes
N/A
Observational 500 participants sought
CHRISTUS Spohn Hospital Corpus Christi-Shoreline — Corpus Christi, Texas (5.3 mi)
· Sponsor: CHRISTUS Health
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 1,840 participants sought
GSK Investigational Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: GlaxoSmithKline
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
Endometriosis, Diagnosis
Phase 2
Interventional 75 participants sought
Corpus Christi Women's Center — Corpus Christi, Texas (5.3 mi)
· Sponsor: Hera Biotech, Inc.
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2
Interventional 153 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Multiple conditions
Phase 3
Interventional 1,780 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group